Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Neoadjuvant Operable Breast Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1088 Carcinoma, Non-Small-Cell Lung 776 Prostatic Neoplasms 626 Neoplasms 522 Multiple Myeloma 461 Lymphoma 458 Colorectal Neoplasms 456 Lung Neoplasms 450 Leukemia 426 Neoplasm Metastasis 406 Leukemia, Myeloid, Acute 395 Melanoma 376 Ovarian Neoplasms 345 Lymphoma, Non-Hodgkin 345 Leukemia, Lymphocytic, Chronic, B-Cell 326 Pancreatic Neoplasms 320 Recurrence 293 Precursor Cell Lymphoblastic Leukemia-Lymphoma 270 Glioblastoma 257 Head and Neck Neoplasms 255 Lymphoma, Large B-Cell, Diffuse 253 Brain Neoplasms 248 Stomach Neoplasms 244 Myelodysplastic Syndromes 244 Lymphoma, Follicular 238 Carcinoma, Renal Cell 229 Rectal Neoplasms 221 Hodgkin Disease 218 Carcinoma, Hepatocellular 218 Sarcoma 214

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡